Russell Van Dyke

Dr. Russell Van Dyke is a Clinical Professor and Section Chief of Pediatric Infectious Diseases at Tulane University School of Medicine. His affiliations include primary appointment at Tulane, collaborative roles in the Pediatric HIV/AIDS Cohort Study (PHACS) and International Maternal Adolescent and Pediatric AIDS Clinical Trials Network, with prior training at Medical College of Wisconsin and UC San Diego.

His research expertise spans:

• Antiviral chemotherapy and sensitivity testing
• Rapid viral diagnostics
• Immunologic responses to respiratory syncytial virus
• Development of RSV monoclonal antibodies
• Perinatal HIV epidemiology, prevention, and treatment
• Pathogenesis of vertical HIV transmission
• HTLV-1/II infection epidemiology
• Long-term outcomes of youth with perinatal HIV

Recent publications (2016-2017) predominantly investigate perinatal HIV outcomes through cohort studies, examining neurocognitive impacts, metabolic complications, viral dynamics, and antiretroviral safety. Work frequently involves multi-center collaborations like PHACS.

Awards recognizing his research include:

• CDC Charles C. Shepard Science Award (2005)
• Tulane Board of Governors Awards for Research Leadership & Distinction (2007)
• CDC James H. Nakano Citation Award (2016)

Dr. Van Dyke leads studies on antiretroviral safety (e.g., PHACS SMARTT) and perinatal HIV outcomes through NIH-funded cohort initiatives, focusing on translational impacts for pediatric HIV care.